The sale is small relative to market cap and executed under a pre-arranged 10b5-1 plan, reducing the likelihood of opportunistic insider selling. Monitor for any acceleration of insider sales or changes in the 10b5-1 plan.
ONC drugs
ONC drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $406.96entry
- T+1 · 8d ago +2.55%α +0.18% · $417.33
- T+5 · 4d ago +2.35%α −0.24% · $416.54
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Chan Lee, an officer of BeOne Medicines Ltd., filed a Form 144 notice of intent to sell 1,115 ADSs with an approximate market value of $421,224.70. The sale is scheduled for November 5, 2026, and is part of a pre-arranged 10b5-1 trading plan established on July 29, 2022. The filing also references a prior sale of 2,666 ADSs on August 11, 2026, for $959,760.
Key Facts
- Chan Lee, an officer, filed Form 144 to sell 1,115 ADSs.
- Estimated market value of the proposed sale is $421,224.70.
- Sale is scheduled for November 5, 2026.
- The sale is part of a 10b5-1 trading plan established on July 29, 2022.
- A prior sale of 2,666 ADSs on August 11, 2026, for $959,760 is also referenced.
Financial Impact
Proposed sale of 1,115 ADSs valued at approximately $421,225, representing a negligible fraction of the $40.4B market cap.
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur.
- The filing references a prior larger sale (2,666 ADSs) in August 2026, which could indicate a pattern of insider monetization.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010750 |
| Document: 0001950047-26-010750-index.html | 0001950047-26-010750 |
| Document: 0001950047-26-010750.txt | 0001950047-26-010750 |
Track record
27 reports on ONC
3 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +12.55% at T+60 after the Aug 5, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $416.54 Now $411.29 −1.26% settles Nov 23
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $419.98 Now $411.29 −2.07% settles Nov 18
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $417.33 to $411.29 Now $411.29 −1.45% ▼ −1.45% +0.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Viewing Entry $406.96 to $416.54 Now $411.29 +1.06% ▲ +2.35% −0.24% vs SPY
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $387.25 to $415.96 Now $411.29 +6.21% ▲ +7.41% +4.12% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $377.78 to $419.98 Now $411.29 +8.87% ▲ +11.17% +12.08% vs SPY
- Oct 2, 20266w ago Insider Cluster Bearish 5/10 Entry $361.65 to $350.40 Now $411.29 −13.73% ▲ +3.11% +3.53% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $368.08 to $365.27 Now $411.29 +11.74% ▼ −0.76% +0.42% vs SPY
- Sep 10, 20269w ago Insider Cluster Neutral 3/10 Entry $346.51 to $350.84 Now $411.29 +18.69% ▲ +1.25% +1.47% vs SPY
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $358.26 to $353.83 Now $411.29 +14.80% ▼ −1.24% −0.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers